Clinical trialRSSToday
A new treatment called Roctavian was given as a single injection to men with severe hemophilia A (a bleeding disorder). Seven years later, most patients had fewer bleeding episodes and needed less preventive medicine. This suggests the treatment's benefits can last for many years.
WHY IT MATTERSIf you have severe hemophilia A, Roctavian could mean switching from frequent infusions or injections to a single treatment that protects you from bleeds for years.
AdvocacyRSSToday
A person recently attended the Hemophilia Federation of America's annual symposium in New Orleans and shared their positive experience meeting others in the hemophilia community. The event inspired reflection on both current progress in treating hemophilia and the difficult history the community has faced. The author expressed gratitude for being included and highlighted the importance of gathering with others who understand the challenges of living with a bleeding disorder.
WHY IT MATTERSCommunity events like the HFA Symposium provide hemophilia patients and caregivers with opportunities to connect with others, learn about new treatments, and access support networks that can improve quality of life and treatment decisions.
AdvocacyRSS2 days ago
A mother shares her personal story about raising two sons with hemophilia, a bleeding disorder that prevents blood from clotting properly. She describes how the condition has affected her family's life and what it means to be a caregiver for young men living with this lifelong disease. The article uses her childhood memory of wanting to do gymnastics as a contrast to the physical limitations and challenges her sons face.
WHY IT MATTERSParents and caregivers of people with hemophilia can find community and validation in hearing directly from other families navigating the same daily challenges of managing a chronic bleeding disorder.
AdvocacyRSS2 days ago
A parent shares their experience helping their 7-year-old daughter with hemophilia participate in swimming lessons despite physical limitations. The article emphasizes that having a rare bleeding disorder doesn't prevent children from enjoying typical childhood activities and building confidence through sports and recreation.
WHY IT MATTERSParents of children with hemophilia can learn practical strategies for safely enabling their kids to participate in normal activities like swimming, which can improve physical health and emotional well-being.
NewsRSS2 days ago
People with bleeding disorders like hemophilia face daily challenges that go beyond medical treatment. Getting dressed requires careful thought about activities planned for the day, since certain movements or pressure on the body can trigger bleeding. This personal essay shows how bleeding disorders affect everyday life decisions that most people never have to consider.
WHY IT MATTERSPeople with bleeding disorders need to plan physical activities carefully to avoid injuries that could cause internal bleeding, making even routine tasks like choosing clothes a strategic health decision.
AdvocacyRSS2 days ago
World Hemophilia Day on April 17 is highlighting the importance of getting diagnosed early and accurately for hemophilia and other bleeding disorders. Early diagnosis is being emphasized as a crucial first step that helps people with hemophilia manage their condition better and live healthier lives.
WHY IT MATTERSEarly and accurate diagnosis of hemophilia can significantly impact treatment outcomes and quality of life, making this awareness campaign directly relevant to patients seeking to optimize their care.
ResearchPUBMED3 days ago
Researchers in Germany studied health insurance records from 2017-2019 to understand how hemophilia A (a bleeding disorder) affects patients and how much it costs to treat. They found 257 patients with hemophilia A and grouped them by severity—mild, moderate, or severe—based on how much clotting medicine they needed. This study shows that insurance data can help doctors and researchers learn more about rare diseases like hemophilia A.
WHY IT MATTERSIf you have hemophilia A in Germany, this research demonstrates that your health insurance claims data can be used to better understand disease patterns, treatment costs, and care gaps—potentially leading to improved healthcare planning and resource allocation for your condition.
Clinical trialUNITERAREApr 3
This is a clinical trial testing a blood clotting medicine called Nuwiq in women and girls with hemophilia A who need surgery. Hemophilia A is a rare bleeding disorder where the body doesn't make enough of a protein that helps blood clot. The trial will study how well Nuwiq works and what dose is best for these patients during surgical procedures.
WHY IT MATTERSThis trial is specifically designed for women and girls with hemophilia A undergoing surgery — a population that often receives less research attention than males with the same condition.